Trial Profile
A Phase IV Pilot Study to Assess Community-Based Treatment Efficacy in Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2020
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 25 Oct 2020 Results presented at the IDWeek 2020
- 16 Jul 2018 Status changed from active, no longer recruiting to completed.
- 08 Aug 2017 Results published in the Annals of Internal Medicine